Tratamiento de la EPOC en 5 ciudades de América Latina: estudio PLATINO

Tratamiento de la EPOC en 5 ciudades de América Latina: estudio PLATINO

Alternative title Treatment of chronic obstructive pulmonary disease in 5 Latin American cities: The PLATINO study
Author Varela, Maria Victorina Lopez Google Scholar
Muino, Adriana Google Scholar
Padille, Rogelio Perez Google Scholar
Jardim, Jose Roberto Autor UNIFESP Google Scholar
Talamo, Carlos Google Scholar
Oca, Maria Montes de Google Scholar
Valdivia, Gonzalo Google Scholar
Pertuze, Julio Google Scholar
Halbert, Ron Google Scholar
Menezes, Ana Maria Google Scholar
Marquez, Maria Google Scholar
Hallal, Pedro Google Scholar
Moreno, Dolores Google Scholar
Rosa, Fernanda Google Scholar
Carnelier, Aquiles Google Scholar
Institution Univ Republica
Inst Entermedades Respirat
Universidade Federal de São Paulo (UNIFESP)
Univ Cent Venezuela
Pontificia Univ Catolica Chile
Univ Calif Los Angeles
Univ Fed Pelotas
Abstract OBJECTIVE: PLATINO project is a population-based study designed to determine the prevalence of chronic obstructive pulmonary disease (COPD) in S (a) over tildeo Paulo, Brazil; Mexico City, Mexico; Montevideo, Uruguay; Santiago de Chile, Chile; and Caracas, Venezuela. The objective of this portion of PLATINO was to describe preventive and pharmacological treatment of COPD patients and factors associated with such treatment.PATIENTS AND METHODS: Eligible subjects completed a questionnaire and underwent postbronchodilator spirometry.RESULTS: Of the total of 5529 individuals who answered items referring to treatment, 758 had COPD (ratio of postbronchodilator forced expiratory volume in 1 second to forced vital capacity of <0.7), and 86 of them had been previously diagnosed by a physician. Among all COPD patients, only half of smokers or former smokers had been advised to quit and 24.7% had received some type of respiratory medication. Only 13.5% had used inhaled corticosteroids, and those were the patients with the most severe disease. In the group of patients who had a previous medical diagnosis of COPD, 69% of the smokers or former smokers had been advised to quit by a physician and 75.6% had received respiratory medication in the preceding year: 43% reported having used inhaled medication and 36% had used bronchodilators. Rates of vaccination against influenza and the use of mucolytic drugs and inhalers varied from one health care facility to another. All drug prescriptions were based on previous spirometry.CONCLUSIONS: Spirometry emerged not only as a diagnostic tool, but also as a factor associated with treatment, against a background of uneven use of available health care resources in these 5 Latin American cities.
Keywords chronic obstructive pulmonary disease (COPD)
population-based study
preventive treatment
respiratory medication
Language Spanish
Date 2008-02-01
Published in Archivos De Bronconeumologia. Barcelona: Ediciones Doyma S A, v. 44, n. 2, p. 58-64, 2008.
ISSN 0300-2896 (Sherpa/Romeo, impact factor)
Publisher Ediciones Doyma S A
Extent 58-64
Access rights Closed access
Type Article
Web of Science ID WOS:000253402700002

Show full item record


File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)




My Account